ConvaTec Group (OTCMKTS:CNVVY) Upgraded by Sanford C. Bernstein to Strong-Buy Rating

ConvaTec Group (OTCMKTS:CNVVY) was upgraded by investment analysts at Sanford C. Bernstein to a “strong-buy” rating in a report issued on Wednesday,Zacks.com reports.

Separately, Peel Hunt upgraded shares of ConvaTec Group from a “moderate buy” rating to a “strong-buy” rating in a report on Tuesday, October 28th. Two equities research analysts have rated the stock with a Strong Buy rating, According to data from MarketBeat, ConvaTec Group has a consensus rating of “Strong Buy”.

ConvaTec Group Price Performance

CNVVY opened at $12.64 on Wednesday. ConvaTec Group has a 52 week low of $11.57 and a 52 week high of $16.65. The business’s fifty day simple moving average is $12.70 and its 200 day simple moving average is $12.77.

ConvaTec Group Company Profile

ConvaTec Group is a global medical products and technologies company focused on developing therapies and technologies for the management of chronic health conditions. The company’s portfolio spans four core business areas—Advanced Wound Care, Ostomy Care, Continence & Critical Care, and Infusion Devices—which are designed to improve patient outcomes and enhance quality of life for people living with long-term health challenges. ConvaTec’s product range includes proprietary wound dressings, ostomy and continence management systems, and safety-engineered infusion sets.

Headquartered in Reading, United Kingdom, ConvaTec serves customers in over 100 countries through a network of manufacturing, distribution, and customer support operations.